Changes in cell and tissue organization in cancer of the breast and colon.

Most cancers arise in epithelia, the tissue type that lines all body cavities. The organization of epithelia enables them to act as a barrier and perform vectorial transport of molecules between body compartments. Crucial for their organization and function is a highly specialized network of cell adhesion and polarity proteins aligned along the apical-basal axis. Comparing breast and intestinal tissue as examples of common cancer sites, reveals an important contribution of polarity proteins to the initiation and progression of cancer. Defects in polarity are induced directly by mutations in polarity proteins, but also indirectly by changes in the expression of specific microRNAs and altered transcriptional programs that drive cellular differentiation from epithelial to more mesenchymal characteristics. The latter is particularly important in the metastatic process.

[1]  Nam-Gyun Kim,et al.  p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling , 2011, Science Signaling.

[2]  W. Dove,et al.  Intestinal adenomagenesis involves core molecular signatures of the epithelial–mesenchymal transition , 2008, Journal of Molecular Histology.

[3]  Wenlin Huang,et al.  Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. , 2013, Gastroenterology.

[4]  J. Montalbano,et al.  Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. , 2012, Cancer cell.

[5]  Gregory J Goodall,et al.  Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. , 2013, Neoplasia.

[6]  Peter Kuhn,et al.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors , 2012, Physical biology.

[7]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[8]  Chiara Romualdi,et al.  miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Piotr J. Balwierz,et al.  Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. , 2013, Cancer cell.

[10]  W. Bodmer,et al.  Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. , 2003, Cancer research.

[11]  Z. Werb,et al.  GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression , 2013, Nature Cell Biology.

[12]  Nicholas C. Flytzanis,et al.  An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype , 2011, PLoS genetics.

[13]  S. Rocha,et al.  Adenomatous Polyposis Coli and Hypoxia-inducible Factor-1α Have an Antagonistic Connection , 2010, Molecular biology of the cell.

[14]  L. Terracciano,et al.  Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair‐proficient and ‐deficient colorectal cancers , 2011, Histopathology.

[15]  P. Appleton,et al.  Cell and tissue polarity in the intestinal tract during tumourigenesis: cells still know the right way up, but tissue organization is lost , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[16]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[17]  S. Nelson,et al.  Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance , 2013, Journal of Cell Science.

[18]  T. Brabletz,et al.  β‐Catenin activates a coordinated expression of the proinvasive factors laminin‐5 γ2 chain and MT1‐MMP in colorectal carcinomas , 2004 .

[19]  M. Delorenzi,et al.  microRNAs in colon cancer: A roadmap for discovery , 2012, FEBS letters.

[20]  M. H. Chui.  Insights into cancer metastasis from a clinicopathologic perspective: Epithelial‐Mesenchymal Transition is not a necessary step , 2013, International journal of cancer.

[21]  Caroline Dive,et al.  Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  Taher A. Saif,et al.  Attenuation of Cell Mechanosensitivity in Colon Cancer Cells during In Vitro Metastasis , 2012, PloS one.

[23]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[24]  The Colony Forming Efficiency of Single Cells and Cell Aggregates from a Spontaneous Mouse Mammary Tumour Using the Lung Colony Assay , 1974, British Journal of Cancer.

[25]  Robert M. Hoffman,et al.  Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force , 2013, The Journal of cell biology.

[26]  Hanlin L. Wang,et al.  Colorectal carcinoma: Pathologic aspects. , 2012, Journal of gastrointestinal oncology.

[27]  John G. Collard,et al.  Cell polarity proteins and cancer. , 2012, Seminars in cancer biology.

[28]  Kevin W. Eliceiri,et al.  The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis , 2013, Nature Cell Biology.

[29]  K. Vecchio,et al.  Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness. , 2012, Biomaterials.

[30]  Ian P Newton,et al.  Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. , 2004, Genes & development.

[31]  C. Lim,et al.  Isolation and retrieval of circulating tumor cells using centrifugal forces , 2013, Scientific Reports.

[32]  A. Hall,et al.  Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity , 2003, Nature.

[33]  T. Brabletz,et al.  Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. , 2004, International journal of cancer.

[34]  D. Allred,et al.  Loss of Par3 promotes breast cancer metastasis by compromising cell–cell cohesion , 2012, Nature Cell Biology.

[35]  G. Goodall,et al.  microRNAs and EMT in Mammary Cells and Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[36]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[37]  Woo Kyung Moon,et al.  Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer , 2013, European Radiology.

[38]  M. Loeffler,et al.  Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. , 1990, Development.

[39]  Guojun Wu,et al.  The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis , 2012, Cancer and Metastasis Reviews.

[40]  M. Esteller,et al.  Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis , 2011, Oncogene.

[41]  J. Schlom,et al.  Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity , 2011, Experimental biology and medicine.

[42]  W. Weis,et al.  Roles of cadherins and catenins in cell-cell adhesion and epithelial cell polarity. , 2013, Progress in molecular biology and translational science.

[43]  Steve Horvath,et al.  Higher levels of GATA3 predict better survival in women with breast cancer. , 2010, Human pathology.

[44]  A. Postigo,et al.  β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness , 2011, Proceedings of the National Academy of Sciences.